Search results for "Stroke"


 
Results 1 - 10 of about 987 for "Stroke".
Sort by: Relevance | Newest | Oldest

Current tools insufficient to guide anticoagulation decisions for new-onset AF in sepsis

The most commonly used stroke risk calculator does not predict postsepsis stroke and should not be used to guide decisions about anticoagulation among patients with new-onset atrial fibrillation (AF) and sepsis, a new study concluded.
https://acphospitalist.acponline.org/archives/2024/04/17/current-tools-insufficient-to-guide-anticoagulation-decisions-for-new-onset-af-in-sepsis.htm
17 Apr 2024

Early minimally invasive surgery may improve outcomes for certain intracerebral hemorrhages

An industry-sponsored trial found that functional outcomes at 180 days were better with minimally invasive hematoma evacuation plus guideline-based medical management than medical management alone, if surgery could be done within 24 hours.
https://acphospitalist.acponline.org/archives/2024/04/17/early-minimally-invasive-surgery-may-improve-outcomes-for-certain-intracerebral-hemorrhages.htm
17 Apr 2024

Antibiotic OKed for pneumonia, bloodstream, skin infections

In addition to approving ceftobiprole medocaril sodium for three different types of infection, the FDA authorized the first generic version of fidaxomicin, among other actions.
https://acphospitalist.acponline.org/archives/2024/04/10/antibiotic-oked-for-pneumonia-bloodstream-skin-infections.htm
10 Apr 2024

Two in five HF patients not on guideline-directed medical therapy at discharge

A study of Veterans Affairs hospitals found that 42% of patients hospitalized for heart failure (HF) in 2013 to 2019 were not prescribed all guideline-recommended medications at discharge, and those receiving care at urban hospitals were even less likely to receive the treatments.
https://acphospitalist.acponline.org/archives/2024/04/10/two-in-five-hf-patients-not-on-guideline-directed-medical-therapy-at-discharge.htm
10 Apr 2024

First medication for severe frostbite approved

The FDA also warned about smartwatches claiming to measure blood sugar without piercing the skin, among other recent actions.
https://acphospitalist.acponline.org/archives/2024/03/06/first-medication-for-severe-frostbite-approved.htm
6 Mar 2024

Timing of stroke treatment, preventive therapies presented at stroke meeting

Mostly disappointing results on transfers for thrombectomy, delayed use of thrombolysis plus thrombectomy or tenecteplase, and anticoagulation for secondary prevention after cryptogenic stroke were reported at the International Stroke Conference.
https://acphospitalist.acponline.org/archives/2024/02/14/timing-of-stroke-treatment-preventive-therapies-presented-at-stroke-meeting.htm
14 Feb 2024

Analysis highlights poor outcomes, inconsistent treatment of catastrophic PE

Pulmonary embolism (PE) patients with hemodynamic collapse had a 42.1% risk of mortality, according to data from the Pulmonary Embolism Response Team registry. Only 13.3% of such patients underwent extracorporeal membrane oxygenation and 25% got systemic thrombolysis.
https://acphospitalist.acponline.org/archives/2024/01/10/analysis-highlights-poor-outcomes-inconsistent-treatment-of-catastrophic-pe.htm
10 Jan 2024

Risk factors may not accurately identify complicated Staphylococcus aureus bacteremia

The Infectious Diseases Society of America's criteria for determining complicated S. aureus bacteremia had low to moderate predictive value and could lead to unnecessary antibiotic treatment, according to a prospective cohort study in the Netherlands.
https://acphospitalist.acponline.org/archives/2024/01/10/risk-factors-may-not-accurately-identify-complicated-staphylococcus-aureus-bacteremia.htm
10 Jan 2024

Catching postop problems

An expert offers tips on dealing with postoperative fever, urinary retention, nausea and vomiting, acute kidney injury, and atrial fibrillation.
https://acphospitalist.acponline.org/archives/2023/11/22/catching-postop-problems.htm
22 Nov 2023

Chinese medicine reduced cardiac events after STEMI, trial finds

The randomized trial found fewer major cardiac and cerebrovascular events at 30 days and one year after ST-segment elevation myocardial infarction (STEMI) in patients given Tongxinluo for a year compared to those who were given a placebo.
https://acphospitalist.acponline.org/archives/2023/10/25/chinese-medicine-reduced-cardiac-events-after-stemi-trial-finds.htm
25 Oct 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next